AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

BSF ENTERPRISE PLC

Board/Management Information Apr 28, 2025

5346_rns_2025-04-28_66f6a3a1-b6d9-4404-a5d9-d3aaa75c4cd7.html

Board/Management Information

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 4243G

BSF Enterprise PLC

28 April 2025

London, 28 April 2025

BSF Enterprise PLC 

Strategic Investment

BSF Enterprise PLC ("BSF" or the "Company"), a leading innovator in tissue-engineered materials, is pleased to announce that it has conditionally placed 4,725,000 new ordinary shares in the Company ("Placing Shares") raising £141,750 at 3p per share in a placing ("Placing") within the Company's remaining headroom for shares available under the Financial Conduct's Authority Rules.

Shard Capital is acting as sole broker to the Company.

In light of the significant news on T-Rex leather last Friday we had some small additional headroom for investment and this fundraise represents continuing support from the Company's largest shareholder to bolster the Company's strategic business and growth plans, with the possibility of significant value inflection points throughout  2025.

Completion of the Placing is conditional on, inter alia, the Placing Shares being admitted to listing on the Equity Shares (transition) category of the Official List and to trading on the London Stock Exchange's main market for listed securities ("Admission"). Admission is expected before 15 May 2025.

Applications will be made to the FCA and to the London Stock Exchange for Admission in respect of all the Placing Shares proposed to be issued on completion of the Placing. 

The rights attaching to the Placing Shares will rank pari passu with the existing ordinary shares of the Company. This announcement contains inside information for the purposes of Article 7 of Regulation 2014/596/EU which is part of domestic UK law pursuant to the Market Abuse (Amendment) (EU Exit) regulations (SI 2019/310).

Contact Information  For further information, please visit:  www.bsfenterprise.com


For further enquiries, please visit www.bsfenterprise.com or contact:

BSF Enterprise PLC
Geoff Baker - Executive Director

Che Connon - CEO & Director
Shard Capital (Broker)
Damon Heath

Isabella Pierre
0207 186 9000

0207 186 9927

About BSF Enterprise PLC

BSF Enterprise PLC (BSF) develops and commercialises cutting-edge tissue-engineered solutions, including lab-grown leather, cultivated meat, and corneal repair technologies. By leveraging its proprietary scaffold-free platform, BSF aims to deliver sustainable alternatives to traditional materials and meet global demand for environmentally responsible innovations.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCPPUWCCUPAURR

Talk to a Data Expert

Have a question? We'll get back to you promptly.